Trial Details
RECRUITINGBasic Information
| Clinical ID | c1025 |
|---|---|
| Identifier | NCT06570772 |
| Trial Title | Study to Investigate Comparative Efficacy, Safety and Immunogenicity Between AVT16 and Entyvio |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: AVT16|BIOLOGICAL: Vedolizumab |
Participant Information
| Sponsor | Alvotech Swiss AG |
|---|---|
| City | Ciudad Autónoma de BuenosAires |
| Country/Region | Argentina |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2024-09-23 |
|---|---|
| Primary Completion Date | 2026-03-31 |
| Completion Date | 2026-08-31 |